(S)-4-(Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)morpholine, 98.0%, 250mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-fluorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg

1-ethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1{H}-pyrazole, 98%, 100mg

Cinchocaine, 95.0%, 1g

(4S,5S)-4,5-Diphenyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole, 95%, 100mg

(2-Chloro-6-methyl-pyrimidin-4-yl)-cyclopropyl-amine, 95.0%, 250mg

3-Aminopyridazine-4-carbonitrile, 95.0%, 100mg

2-Methyl-4-oxazolemethanol, 95.0%, 5g

METHYL 1-METHYL-6-OXOPYRIDAZINE-3-CARBOXYLATE, 95.0%, 5g

6-Iodo-2-methyl-1,3-benzothiazole, 1g

1-Bromo-2,6-dichlorobenzene, 99.0%, 250g

6-Chloro-2-methoxynicotinic acid, 95.0%, 25g

N-(4-Hydroxyphenyl)methacrylamide>98.0%(GC)(T)25g